Celator Pharmaceuticals, Inc. and Cephalon, Inc. Agree to Extend Research Agreement into Next Phase of Development

Published: Jan 10, 2011

(BUSINESS WIRE)--Celator Pharmaceuticals today announced that it has agreed with Cephalon, Inc. to extend an existing research agreement into the next phase of development. The research agreement provides for the utilization of Celator's proprietary technology in an ongoing drug development and life-cycle management program at Cephalon.

Back to news